LGA
TECH icon

Lebenthal Global Advisors’s Bio-Techne TECH Stock Holding History

Lebenthal Global Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,640
Closed -$467K – 132
2022
Q4 		$467K Buy
5,640
+256
+5% +$20.3K 0.15% 76
2022
Q3 		$382K Buy
5,384
+636
+13% +$55K 0.18% 74
2022
Q2 		$411K Buy
4,748
+80
+2% +$7.5K 0.2% 79
2022
Q1 		$505K Buy
4,668
+280
+6% +$28.9K 0.22% 81
2021
Q4 		$567K Buy
+4,388
New +$538K 0.23% 63

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Lebenthal Global Advisors's TECH Position: Q1 2023 in Review

Lebenthal Global Advisors sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 5,640 shares — an estimated $467K sold.

Lebenthal Global Advisors first reported a position in TECH in Q4 2021 and held it in 5 quarters. The position peaked at $567K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • Lebenthal Global Advisors reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • Lebenthal Global Advisors sold 5,640 Bio-Techne shares in Q1 2023, an estimated $467K.
  • Lebenthal Global Advisors first reported a position in Bio-Techne in Q4 2021 and held it in 5 quarters.
  • Lebenthal Global Advisors's Bio-Techne position peaked at $567K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on Lebenthal Global Advisors's 13F filing for Q1 2023, filed 5 May 2023.